XML 21 R12.htm IDEA: XBRL DOCUMENT
v3.21.4

Derivative Financial Instruments | 6 Months Ended
--- | ---
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative Financial Instruments | Derivative Financial Instruments The Company is exposed to foreign currency exchange rate, interest rate, and to a lesser extent, equity market risks relating to its ongoing business operations. From time to time, the Company enters into cash flow hedges in the form of foreign currency forward exchange contracts in order to manage the foreign currency exchange rate risk on forecasted expenses and investments denominated in foreign currencies. The Company has entered into certain interest rate swap agreements to convert the variable interest rate on its Term Loans to fixed interest rates. The objective of the interest rate swap agreements is to eliminate the variability of interest payment cash flows associated with the variable interest rate under the Term Loans. The Company designated the interest rate swaps as cash flow hedges. As of December 31, 2021, the aggregate notional amount of the Company’s interest-rate swap contracts was $1.2 billion, of which $600 million will mature in September 2025 and $600 million will mature in July 2027. The Company’s accounting policies for these instruments are based on whether the instruments are classified as designated or non-designated hedging instruments. The Company records all derivatives on its Condensed Consolidated Balance Sheets at fair value. The changes in the fair value of highly effective designated cash flow hedges are recorded in Accumulated other comprehensive loss until the hedged item is recognized in earnings. Derivatives that are not designated as hedging instruments or are not assessed to be highly effective are adjusted to fair value through earnings. The amount of net unrealized loss on cash flow hedges was $4 million and $18 million as of December 31, 2021 and as of July 2, 2021, respectively. As of December 31, 2021, the amount of existing net losses related to cash flow hedges recorded in Accumulated other comprehensive loss included a net loss of $10 million that is expected to be reclassified to earnings within twelve months. The Company de-designates its cash flow hedges when the forecasted hedged transactions affect earnings or it is probable the forecasted hedged transactions will not occur in the initially identified time period. At such time, the associated gains and losses deferred in Accumulated other comprehensive loss on the Company’s Condensed Consolidated Balance Sheets are reclassified into earnings and any subsequent changes in the fair value of such derivative instruments are immediately reflected in earnings. The Company recognized a net loss of $6 million and $3 million in Cost of revenue and Interest expense, respectively, related to the loss of hedge designation on discontinued cash flow hedges during the three months ended December 31, 2021. The Company recognized a net loss of $8 million and $4 million in Cost of revenue and Interest expense, respectively, related to the loss of hedge designation on discontinued cash flow hedges during the six months ended December 31, 2021. The Company recognized a net gain of $4 million in Cost of revenue related to the loss of hedge designation on discontinued cash flow hedges during the three and six months ended January 1, 2021. The Company recognized a net loss of $2 million and $4 million in Other, net related to the loss of hedge designation on discontinued cash flow hedges during the three and six months ended January 1, 2021, respectively. Other derivatives not designated as hedging instruments consist of foreign currency forward exchange contracts that the Company uses to hedge the foreign currency exposure on forecasted expenditures denominated in currencies other than the U.S. dollar. The Company recognizes gains and losses on these contracts, as well as the related costs in Other, net on its Condensed Consolidated Statements of Operations. The following tables show the total notional value of the Company’s outstanding foreign currency forward exchange contracts as of December 31, 2021 and July 2, 2021. All of the foreign currency forward exchange contracts mature within 12 months.
|  | As of December 31, 2021
(Dollars in millions) |  | Contracts Designated as Hedges |  | Contracts Not Designated as Hedges
Singapore Dollar |  | $ | 170 |  |  | $ | 54 |
Thai Baht |  | 130 |  |  | 42 |
Chinese Renminbi |  | 84 |  |  | 22 |
British Pound Sterling |  | 65 |  |  | 18 |
|  | $ | 449 |  |  | $ | 136 |
|  | As of July 2, 2021
(Dollars in millions) |  | Contracts Designated as Hedges |  | Contracts Not Designated as Hedges
Singapore Dollar |  | $ | 172 |  |  | $ | 43 |
Thai Baht |  | 131 |  |  | 46 |
Chinese Renminbi |  | 73 |  |  | 21 |
British Pound Sterling |  | 54 |  |  | 16 |
|  | $ | 430 |  |  | $ | 126 |
The Company is subject to equity market risks due to changes in the fair value of the notional investments selected by its employees as part of its non-qualified deferred compensation plan: the Seagate Deferred Compensation Plan (the “SDCP”). In fiscal year 2014, the Company entered into a Total Return Swap (“TRS”) in order to manage the equity market risks associated with the SDCP’s liabilities. The Company pays a floating rate, based on LIBOR plus an interest rate spread, on the notional amount of the TRS. The TRS is designed to substantially offset changes in the SDCP’s liabilities due to changes in the value of the investment options made by employees. As of December 31, 2021, the notional investments underlying the TRS amounted to $133 million and the contract term was through January 2022, settled on a monthly basis, limiting counterparty performance risk. As of January 25, 2022, the contract term of the TRS was extended through January 2023. The Company did not designate the TRS as a hedge. Rather, the Company records all changes in the fair value of the TRS to earnings to offset the market value changes of the SDCP’s liabilities. The following tables show the Company’s derivative instruments measured at gross fair value as reflected in the Condensed Consolidated Balance Sheets as of December 31, 2021 and July 2, 2021:
|  | As of December 31, 2021
|  | Derivative Assets |  | Derivative Liabilities
(Dollars in millions) |  | Balance Sheet Location |  | Fair Value |  | Balance Sheet Location |  | Fair Value
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |
Foreign currency forward exchange contracts |  | Other current assets |  | $ | 1 |  |  | Accrued expenses |  | $ | (2) |
Interest rate swap |  | Other current assets |  | 2 |  |  | Accrued expenses |  | (5) |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |
Foreign currency forward exchange contracts |  | Other current assets |  | 1 |  |  | Accrued expenses |  | (3) |
Total derivatives |  |  |  | $ | 4 |  |  |  |  | $ | (10) |
|  | As of July 2, 2021
|  | Derivative Assets |  | Derivative Liabilities
(Dollars in millions) |  | Balance Sheet Location |  | Fair Value |  | Balance Sheet Location |  | Fair Value
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |
Foreign currency forward exchange contracts |  | Other current assets |  | $ | 1 |  |  | Accrued expenses |  | $ | (5) |
Interest rate swap |  | Other current assets |  | — |  |  | Accrued expenses |  | (14) |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |
Foreign currency forward exchange contracts |  | Other current assets |  | 1 |  |  | Accrued expenses |  | (2) |
Total return swap |  | Other current assets |  | 2 |  |  | Accrued expenses |  | — |
Total derivatives |  |  |  | $ | 4 |  |  |  |  | $ | (21) |
The following tables show the effect of the Company’s derivative instruments on the Condensed Consolidated Statements of Comprehensive Income and the Condensed Consolidated Statements of Operations for the three and six months ended December 31, 2021:
|  |  |  | Amount of Gain/(Loss) Recognized in Income on Derivatives
(Dollars in millions) Derivatives Not Designated as Hedging Instruments |  | Location of Gain/(Loss) Recognized in Income on Derivatives |  | For the Three Months |  | For the Six Months
Foreign currency forward exchange contracts |  | Other, net |  | $ | 2 |  |  | $ | (2) |
Total return swap |  | Operating expenses |  | 7 |  |  | 6 |
(Dollars in millions) Derivatives Designated as Hedging Instruments |  | Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion) |  | Location of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | Location of Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) |  | Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)
| For the Three Months |  | For the Six Months |  |  | For the Three Months |  | For the Six Months |  |  | For the Three Months |  | For the Six Months
Foreign currency forward exchange contracts |  | $ | 4 |  |  | $ | (5) |  |  | Cost of revenue |  | $ | (6) |  |  | $ | (8) |  |  | Other, net |  | $ | — |  |  | $ | 1 |
Interest rate swap |  | 7 |  |  | 7 |  |  | Interest expense |  | (3) |  |  | (4) |  |  | Interest expense |  | — |  |  | — |
The following tables show the effect of the Company’s derivative instruments on the Condensed Consolidated Statements of Comprehensive Income and the Condensed Consolidated Statements of Operations for the three and six months ended January 1, 2021:
(Dollars in millions) Derivatives Not Designated as Hedging Instruments |  | Location of Gain/(Loss) Recognized in Income on Derivatives |  | Amount of Gain/(Loss) Recognized in Income on Derivatives
|  | For the Three Months |  | For the Six Months
Foreign currency forward exchange contracts |  | Other, net |  | $ | 6 |  |  | $ | 14 |
Total return swap |  | Operating expenses |  | $ | 11 |  |  | $ | 16 |
(Dollars in millions) Derivatives Designated as Hedging Instruments |  | Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion) |  | Location of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |  | Location of Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) |  | Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)
| For the Three Months |  | For the Six Months |  |  | For the Three Months |  | For the Six Months |  |  | For the Three Months |  | For the Six Months
Foreign currency forward exchange contracts |  | $ | 11 |  |  | $ | 15 |  |  | Cost of revenue |  | $ | 4 |  |  | $ | 4 |  |  | Other, net |  | $ | 1 |  |  | $ | 1 |
Interest rate swap |  | 1 |  |  | 1 |  |  | Interest expense |  | (2) |  |  | (4) |  |  | Interest expense |  | — |  |  | — |

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration